Drug Research
Quotient Sciences Supports Crinetics Pharmaceuticals with Fully Integrated Pediatric Development and Clinical Testing Program
Crinetics Pharmaceuticals, a pharmaceutical company that develops therapies for rare endocrine diseases, and Quotient Sciences, a drug development and manufacturing accelerator, have announced a partnership...
Drug Research
Immunotherapy Efficacy Shown Through New Delivery Approach
Intrathecal (IT), intravenous (IV), and Nivolumab (anti-PD-1) immunotherapy were found to be safe and prolong life in a subset of melanoma individuals with leptomeningeal illness...
Drug Research
EMA Releases Mid-Point Regulatory Science Strategy Study
The European Medicines Agency (EMA) has released a paper summarizing its Regulatory Science Strategy (RSS) mid-point achievements through 2025. Originally released in March 2020, the...
Drug Research
Nasal Spray Effective Against Recent Variants – Research
Researchers have identified a molecule that is particularly successful in preventing sickness caused by all known forms of the SARS-CoV-2 virus when put nasally. The...
Drug Research
First Gene Therapy Comes Into Picture For AADC Deficiency
In the final draft guidance rolled out by the National Institute for Health and Care Excellence- NICE, a single-dose therapy, eladocagene exuparvovec, has been recommended...
Drug Research
Australia Offers Hope For Drug Resistant Epilepsy Patients
More than 150,000 Australians and 50 million people across the world are affected by epilepsy, with almost one-third finding it challenging to control the condition...
Drug Research
Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion
Samsung Biologics, a leading contract development and manufacturing organization (CDMO), announced that the company will commence the construction of a fifth plant as part of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.